We use cookies to make sure that our website works properly, as well as some ‘optional’ cookies to personalise content and advertising, provide social media features and analyse how people use our site. Further information can be found in our Cookies policy
Migraine headaches are a widespread neurological issue, affecting millions of people worldwide, and are known for causing severe, disabling pain that can greatly reduce one’s quality of life. Although conventional medications may offer some relief, they are frequently associated with adverse side effects and potential long-term health concerns. This study aims to create a natural, non-invasive balm specifically designed to relieve migraine pain. The balm incorporates lavender oil and chamomile oil, both of which are well-known for their calming and anti-inflammatory properties. Eucalyptus oil is also included to provide a cooling effect, which can help ease headache discomfort. The base of the balm is made from beeswax and petroleum jelly, which allows for smooth application and helps distribute the active ingredients effectively onto the skin. The formulation is easy to apply topically, offering a safer and non-invasive alternative to oral medications. Through an in-depth review of existing research on the effectiveness of essential oils for treating migraines, this study explores the potential of these natural remedies as alternatives to conventional treatments. We expect the balm to reduce both the intensity and frequency of migraine symptoms, providing a more holistic approach to managing migraines. This study adds to the increasing focus on herbal and natural remedies for migraine treatment.
Migraine is a primary headache disorder characterized by recurrent, moderate to severe headaches that are often unilateral and pulsating, lasting between 4 to 72 hours (1). It is frequently associated with nausea, vomiting, photophobia (sensitivity to light), and phonophobia (sensitivity to sound), all of which significantly impair quality of life (2). The International Classification of Headache Disorders (ICHD-3) categorizes migraines into two types:
Migraine with aura – This type includes transient neurological disturbances, such as visual changes (flashes of light, blind spots) or sensory changes (tingling, numbness), before the headache begins (3).
Migraine without aura – The more common form of migraine, occurring without these warning signs (3).
Headache disorders—including migraines, tension-type headaches (TTH), and cluster headaches— affect nearly 40% of the global population (3.1 billion people in 2021) (4). Migraine alone impacts approximately 1.1 billion people worldwide (5). It is three times more common in women than men, largely due to hormonal influences (6). Migraines usually start at puberty and are most common in people aged 35–45 years, though they also affect children and adolescents (4). The impact of migraines extends far beyond pain. It is one of the leading causes of disability adjusted life years (DALYs) worldwide, affecting daily life, work productivity, education, and mental health (4). Many migraine sufferers also experience anxiety and depression, further worsening their quality of life (7). Despite its significant burden, a large number of people remain undiagnosed or untreated, increasing both personal and economic challenges (4).
Existing Treatments for Migraines
Migraine occurs due to dysfunction of the trigeminovascular system, involving cortical spreading depression, neurogenic inflammation, and pain sensitization mediated by calcitonin gene-related peptide (CGRP) (8). Current treatment approaches aim to relieve acute symptoms and prevent future attacks, categorized as follows:
Acute therapies – Used for immediate relief during an attack, including nonsteroidal anti-inflammatory drugs (NSAIDs), triptans, ergotamines, and CGRP antagonists (9).
Preventive therapies – Reduce migraine frequency and severity. Common options include beta-blockers, anti-epileptic drugs (topiramate, valproic acid), antidepressants (amitriptyline), and CGRP monoclonal antibodies (9, 10).
The Role of Topical Treatments
Due to the limitations of oral migraine medications, topical treatments have gained attention as effective alternatives for migraine relief (4). Unlike oral drugs, topical formulations work locally, allowing direct absorption through the skin while minimizing systemic side effects (11). Advantages of Topical Treatments
Localized effect – Targets the affected area directly instead of impacting the entire body (11).
Fewer systemic side effects – Reduces gastrointestinal and cardiovascular risks commonly associated with oral drugs (11).
Improved patient compliance – Non-invasive, easy to use, and provides immediate cooling and analgesic effects (11).
METHODOLOGY
Materials used
Lavender Oil (Lavandula angustifolia)
Fig. Lavender Oil (Lavandula angustifolia)
Source & Extraction
Lavender essential oil is extracted from the flowers of Lavandula angustifolia through steam distillation, preserving its bioactive compounds.
The main constituents are linalool (28.19%) and linalyl acetate (34.90%), which contributes to its analgesic, anti-inflammatory, and calming effects.
Therapeutic Role in Migraine Relief by Topical Application:
Pain Modulation: Linalool interacts with opioid and cannabinoid receptors, contributing to neuropathic pain relief.
GABAergic Activity: Enhances GABA-A receptor function, exerting a calming effect on the nervous system that helps alleviate migraine symptoms.
Aromatherapy Benefits:
Inhalation of lavender oil vapours stimulates the olfactory system, leading to the activation of limbic structures (which regulate emotions and pain perception).
Clinical studies show that lavender oil inhalation can reduce migraine severity and frequency when combined with topical application.
The combined effect of topical absorption and inhalation enhances its therapeutic potential for migraine relief.
Skin Penetration & Absorption
Lipophilic nature allows lavender oil to penetrate the stratum corneum, accumulating in the epidermis and dermis for 4–6 hours.
Functions as a natural penetration enhancer, improving transdermal absorption of other active ingredients in the balm.
Encapsulation in lipid-based carriers improves retention and prevents rapid evaporation, increasing efficacy.
Compatibility with Balm Base Ingredients
Highly compatible with lipid-based excipients such as beeswax, shea butter, and carrier oils.
Shows no adverse interactions with methyl salicylate or camphor, making it suitable for multi-ingredient formulations.
Volatility Considerations: Beeswax reduces evaporation losses, helping retain the active compounds.
Solubility & Stability in Semi-Solid Formulations
Solubility: Highly soluble in lipid-based formulations, but poorly soluble in water.
Stability Considerations: o Exposure to heat, light, and oxygen leads to degradation of linalool and linalyl acetate.
Stored in amber-coloured, airtight containers to maintain potency,
Recommended Addition Temperature: Should be added below 40°C to prevent thermal degradation.
Antioxidants (e.g., vitamin E) can be incorporated to prevent oxidative degradation.
Safety & Regulatory Considerations
Recognized as Generally Recognized as Safe (GRAS) by the FDA.
Patch testing is advised before full application to rule out allergic reactions.
Mild skin irritation may occur in some individuals, particularly at higher concentrations.
Eucalyptus Oil (Eucalyptus globulus)
Fig. Eucalyptus Oil (Eucalyptus globulus)
Source & Extraction
Eucalyptus oil is extracted from Eucalyptus globulus leaves through steam distillation, preserving its active compounds.
The primary constituents include 1,8-cineole (eucalyptol), α-pinene, and limonene, which contribute to its analgesic, anti-inflammatory, and muscle relaxant properties.
Therapeutic Role in Migraine Relief by Topical Application:
Analgesic Effect: Eucalyptus oil acts on nociceptive pain pathways, blocking pain transmission via TRPA1 and TRPM8 receptors, which also contribute to a cooling effect [24].
Muscle Relaxant Effect: The menthol-like cooling sensation provided by 1,8-cineole helps relieve migraine-related muscle tension [24].
Aromatherapy Benefits:
Eucalyptus oil is widely used in migraine aromatherapy, often in combination with Lavender and Peppermint Oils [12].
Clinical surveys indicate that migraine sufferers commonly use Eucalyptus Oil via inhalation or topical application, reporting relief from its anti-inflammatory and cooling effects.
Studies suggest that combined inhalation and topical application further enhance its efficacy in headache relief [19].
Skin Penetration & Absorption
The lipophilic nature of eucalyptol enables rapid penetration through the stratum corneum, reaching the dermal layers within minutes.
Functions as a natural permeation enhancer, improving the transdermal absorption of other active ingredients in the balm [24].
Encapsulation in lipid-based carriers (e.g., solid lipid nanoparticles) enhances retention, controlled release, and stability [24].
Compatibility with Balm Base Ingredients
Petroleum Jelly & Beeswax – Acts as a stable base for eucalyptus oil, ensuring sustained release and skin adherence [24].
Menthol & Camphor – Synergistic effects in pain relief and decongestion, enhancing therapeutic efficacy [24], [26].
Methyl Salicylate – Compatible and enhances anti-inflammatory effects, commonly combined in topical analgesics [24], [25].
Sodium Benzoate – No direct interaction noted, but generally used as a preservative in oil-based formulations [24].
Solubility & Stability in Semi-Solid Formulations
Solubility: Highly soluble in lipophilic formulations, poorly soluble in aqueous systems.
Stability Considerations:
Heat, light, and oxygen exposure lead to oxidation and degradation of eucalyptol [25]. o Stored in amber-coloured, airtight containers to maintain potency [25].
Recommended Addition Temperature: Should be added below 40°C to prevent thermal degradation [26].
o Stimulates blood circulation, producing a warming effect.
o Acts on sensory nerves, creating a mild irritation that reduces deeper pain perception.
7.3 Pharmacological Effects:
o Rubefacient (increases blood flow to applied area).
o Analgesic: Blocks pain signals at nerve endings.
o Antimicrobial & Antiseptic: Helps prevent skin infections.
7.4 Use in Balm:
o Enhances local circulation, aiding in pain relief.
o Commonly used for muscle and joint pain relief.
Sodium Benzoate (Preservative)
Fig. Sodium Benzoate (Preservative)
8.1 Function:
o Prevents microbial growth (bacteria, fungi, yeast), extending product shelf-life.
o Ensures stability and safety of the formulation.
8.2 Use in Balm:
o Protects the balm from contamination and degradation.
o Maintains product consistency and effectiveness over time.
8.3 Regulatory Status: GRAS (Generally Recognized as Safe) when used within recommended limits.
List of Ingredients used in the formulation.
Sr.no.
Ingredient
Function
1.
Coconut oil
Solvent
2.
Eucalyptus oil
Pain reliever
3.
Lavender oil
Pain reliever, migraine relief by aromatherapy
4.
Petroleum jelly
Relieves dry skin, healing
5.
Menthol
Counter irritant
6.
Sodium benzoate
Preservative
7.
Bees wax
Base
8.
Camphor
Powerful analgesic, produces a cooling sensation to numb pain and a warming sensation to increase circulation
Method of preparation of herbal balm formulation
Step 1: Melting the Base Ingredients
Take a clean, dry beaker and place it on a hot plate or in a water bath at 50-60°C.
Add beeswax (1.5-2g) and petroleum jelly (2g) into the beaker and allow them to melt completely while stirring gently.
Once melted, add coconut oil (1.5ml) and mix well to ensure uniformity.
Step 2: Incorporating Menthol and Camphor
Reduce the temperature to below 50°C to prevent the evaporation of volatile components.
Add menthol (1g) and camphor (0.8g) to the melted base and stir until they dissolve completely.
Step 3: Adding Essential Oils (API)
Once the mixture is at 40°C or lower, add eucalyptus oil (0.6ml) and lavender oil (0.3ml).
Stir continuously to ensure uniform dispersion.
Step 4: Adding Preservative
Add vitamin E (0.2ml) or sodium benzoate (0.09g) and mix well.
Step 5: Pouring & Solidification
Pour the mixture into sterilized balm containers while still warm.
Allow it to cool at room temperature until it solidifies completely.
Formulation Table
Sr.no.
Ingredients
Formulation 1
Formulation 2
Formulation 3
1.
Lavender oil
0.42 ml
0.85 ml
1.28 ml
2.
Eucalyptus oil
0.85 ml
1.7 ml
2.55 ml
3.
Coconut oil
1.65 ml
3.3 ml
4.95 ml
4.
Bees wax
3 gm
6 gm
9 gm
5.
Petroleum jelly
3 gm
6 gm
9 gm
6.
Menthol
0.45 gm
0.9 gm
1.35 gm
7.
Camphor
0.45 gm
0.9 gm
1.35 gm
8.
Sodium benzoate
0.1 gm
0.2 gm
gm
EVALUATION
A. Physical properties
The physical appearance of the formulation was checked visually.(25)
Colour
The formulation's colour was evaluated against a white background.
Consistency
The consistency was checked by applying the formulation to the skin.
Odour
The odour of the balm was evaluated by dissolving the balm in water and taking the smell.
Greasiness
The greasiness was measured through application on the skin.
Smoothness The smoothness of the formulation was examined by rubbing the balm between the fingers, noting whether it felt smooth, homogeneous, or rough.
B.Measurement of pH
The pH of the formulated product was measured by using digital pH meter by dipping the glass electrode in to the gel system to cover it completely. The measurement was performed in triplicate and the average of the three readings was recorded.(35)
C. Viscosity
The viscosity of balm was determined by using a Brookfield viscometer.
D. Stability
The physical stability of formulated balm was carried out for one month at room temperature.
E. Spreadability
Spreadability is expressed in terms of time taken by two slides to slip of from balm that is placed in between the slides under the direction of certain load. A shorter separation time indicates superior spreadability. Spreadability is performed by using the following formula:
S = M × L / T
Where,
S =Spreadability
M = weight tied to upper slide,
L =length of glass slides,
T = time take to separate the slides.
F. Washabiity
The balm was applied to the skin then washability with water was checked.(25)
G.Non-irritancy test
The formulated product was applied to the human skin and effects are observed.
RESULT AND DISCUSSION
The physicochemical characteristics of the formulated balm were assessed, including Colour, Odour, Consistency, Smoothness, Greasiness and pH. The formulation demonstrated an appealing appearance and quality with pH level ranging from 6.0 to 8.0, which is within the optimal range for balms. In this study, a migraine pain relief balm was formulated by using various excipients. The balm subsequently was evaluated for the following physical parameters and was found to be satisfactory in terms of appearance and texture. It was easily applicable with fingers, providing a smooth feel without any roughness. The smell of balm was found to be characteristic.
Evaluation
Characteristics
Formulations
F1
F2
F3
Color
Milky white
Milky white
Milky white
Consistency
Good
Good
Good
Odor
Characteristic
Characteristic
Characteristic
Greasiness
Good
Good
Good
Smoothness
Good
Good
Good
pH
6.8
7.2
7.5
Viscosity
60,000cP
73,000cP
77,000cP
Stability
Stable
Stable
Stable
Spreadability
4g.cm/sec
6g.cm/sec
7g.cm/sec
Washability
Washable
Washable
Washable
Non-irritancy test
Irritant
Mild-irritant
Mild-irritant
CONCLUSION
The regular use of allopathic medications for migraine relief often results in adverse side effects. Recently herbal alternatives are considered as safe and effective. Hence there is an increase demand for herbal formulations in global market.In summary, the primary aim of this study was to develop and assess the fundamental physical properties and stability of a migraine pain relief balm. The results of the evaluation indicated that the balm maintain stability, with all basic parameters falling within acceptable ranges. Over a one-month stability assessment, the balm demonstrated physical stability, retaining its smooth texture and good consistency. The herbal migraine pain relief balm was formulated without any particulate matter, exhibiting transparency and compatibility without significant alterations.
Based on the study results it can be concluded that herbal components can be effectively formulated in the form of balm which having excellent migraine pain-relieving property.
REFERENCES
Amiri P, Kazeminasab S, Nejadghaderi SA, Mohammadinasab R, Pourfathi H, Araj-Khodaei M, et al. Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front Neurol. 2022 Feb 23; 12:800605.
Deng L, Chiu IM. A neuropeptide regulates immunity across species. Neuron. 2022 Apr 20;110(8):1275–7.
Dodick DW, Martin V. Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms. Cephalalgia Int J Headache. 2004 Jun;24(6):417–24.
Fleischmann R, Strauß S, Reuter U. Treating episodic migraine with precision: the evolving landscape of targeted therapies driven by insights in disease biology. Expert Opin Biol Ther. 2025 Mar 4;25(3):229–43.
Kopustinskiene DM, Bernatonyte U, Maslii Y, Herbina N, Bernatoniene J. Natural Herbal Non-Opioid Topical Pain Relievers—Comparison with Traditional Therapy. Pharmaceutics. 2022 Nov 29;14(12):2648.
Yip YB, Tse SHM. An experimental study on the effectiveness of acupressure with aromatic lavender essential oil for sub-acute, non-specific neck pain in Hong Kong. Complement Ther Clin Pract. 2006 Feb;12(1):18–26.
Rafie S, Namjoyan F, Golfakhrabadi F, Yousefbeyk F, Hassanzadeh A. Effect of lavender essential oil as a prophylactic therapy for migraine: A randomized controlled clinical trial. J Herb Med. 2016 Mar 1;6(1):18–23.
Koto R, Imamura M, Watanabe C, Obayashi S, Shiraishi M, Sasaki Y, et al. Linalyl Acetate as a Major Ingredient of Lavender Essential Oil Relaxes the Rabbit Vascular Smooth Muscle through Dephosphorylation of Myosin Light Chain: J Cardiovasc Pharmacol. 2006 Jul;48(1):850–6.
Firoozeei TS, Feizi A, Rezaeizadeh H, Zargaran A, Roohafza HR, Karimi M. The antidepressant effects of lavender (Lavandula angustifolia Mill.): A systematic review and meta-analysis of randomized controlled clinical trials. Complement Ther Med. 2021 Jun; 59:102679.
Ghaderi F, Solhjou N. The effects of lavender aromatherapy on stress and pain perception in children during dental treatment: A randomized clinical trial. Complement Ther Clin Pract. 2020 Aug; 40:101182.
Abbaszadeh R, Tabari F, Taherian K, Torabi S. Lavender Aromatherapy in Pain Management: A Review. 2017;
Askeur Y, Adil S, Kamel D. Use of aromatherapy for Migraine pain relief. Curr Perspect Med Aromat Plants CUPMAP [Internet]. 2024 Dec 31 [cited 2025 Apr 25]; Available from: https://dergipark.org.tr/en/doi/10.38093/cupmap.1588807
Bavarsad NH, Bagheri S, Kourosh-Arami M, Komaki A. Aromatherapy for the brain: Lavender’s healing effect on epilepsy, depression, anxiety, migraine, and Alzheimer’s disease: A review article. Heliyon. 2023 Aug;9(8): e18492.
Ben Salah M, Abderraba M, Tarhouni MR, Abdelmelek H. Effects of ultraviolet radiation on the kinetics of in vitro percutaneous absorption of lavender oil. Int J Pharm. 2009 Dec;382(1–2):33–8.
Sasannejad P, Saeedi M, Shoeibi A, Gorji A, Abbasi M, Foroughipour M. Lavender Essential Oil in the Treatment of Migraine Headache: A Placebo-Controlled Clinical Trial. Eur Neurol. 2012 Apr 17;67(5):288–91.
Lee SH, Chow PS, Yagnik CK. Developing Eco-Friendly Skin Care Formulations with Microemulsions of Essential Oil. Cosmetics. 2022 Mar 4;9(2):30.
Guo J, Hu X, Wang J, Yu B, Li J, Chen J, et al. Safety and efficacy of compound methyl salicylate liniment for topical pain: A multicenter real-world study in China. Front Pharmacol. 2022 Oct 21; 13:1015941.
FDA Essential Oil Gras List.
Yuan R, Zhang D, Yang J, Wu Z, Luo C, Han L, et al. Review of aromatherapy essential oils and their mechanism of action against migraines. J Ethnopharmacol. 2021 Jan; 265:113326.
Stone T, Tran J. Effectiveness of eucalyptus for pain management: An integrative review.
Dewanjee S, Sohel M, Hossain MS, Ansari F, Islam MT, Sultana F, et al. A comprehensive review on clinically proven natural products in the management of nerve pain, with mechanistic insights. Heliyon. 2023 May;9(5): e15346.
Fahimnia F, Nemattalab M, Hesari Z. Development and characterization of a topical gel, containing lavender (Lavandula angustifolia) oil loaded solid lipid nanoparticles. BMC Complement Med Ther. 2024 Apr 8;24(1):155.
Mahanty J, Rasheed SH, Kumar S, Singh H, Sharma A. Potential of Essential Oils as Alternative Permeation Enhancers for Transdermal Delivery. World J Tradit Chin Med. 2023 Jul;9(3):258–69.
Sosnowska K, Tomczykowa M, Winnicka K, Kalemba D, Tomczyk M. In vivo evaluation of the antipsoriatic effect of hydrogel with lavandin essential oil and its main components after topical application. Acta Pol Pharm - Drug Res. 2023 Mar 3;79(6):841–54.
Pergolizzi JV, Taylor R, LeQuang JA, Raffa RB, the NEMA Research Group. The role and mechanism of action of menthol in topical analgesic products. J Clin Pharm Ther. 2018 Jun;43(3):313–9.
Fatmawati F, Nirmala N, Muhsinin S. Review of Menthol on Pain Relief Formulations.
Hoang D, Wong A, Olympia RP. Looking Back to Move Forward: The Current State of Research on the Clinical Applications of Camphor- and Menthol-Containing Agents. Cureus. 2023 Jul;15(7): e41426.
Li Z, Zhang H, Wang Y, Li Y, Li Q, Zhang L. The distinctive role of menthol in pain and analgesia: Mechanisms, practices, and advances. Front Mol Neurosci. 2022; 15:1006908.
Kailash Sahu. Development and characterized analgesic herbal balm using herbs as a medicine. GSC Adv Res Rev. 2024 Jun 30;19(3):122–7.
Hejazi L, Mahboubi-Rabbani M, Mahdavi V, Alemi M, Khanniri E, Bayanati M. A critical review on sodium benzoate from health effects to analytical methods. Results Chem. 2024 Oct; 11:101798.
Benites E, Carrillo E, Heras M, Bourne D. Evaluation of a new topical cream to psoriasis treatment: randomized clinical trial. Adv Tradit Med. 2024 Sep;24(3):755–64.
Reference
Amiri P, Kazeminasab S, Nejadghaderi SA, Mohammadinasab R, Pourfathi H, Araj-Khodaei M, et al. Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front Neurol. 2022 Feb 23; 12:800605.
Deng L, Chiu IM. A neuropeptide regulates immunity across species. Neuron. 2022 Apr 20;110(8):1275–7.
Dodick DW, Martin V. Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms. Cephalalgia Int J Headache. 2004 Jun;24(6):417–24.
Fleischmann R, Strauß S, Reuter U. Treating episodic migraine with precision: the evolving landscape of targeted therapies driven by insights in disease biology. Expert Opin Biol Ther. 2025 Mar 4;25(3):229–43.
Kopustinskiene DM, Bernatonyte U, Maslii Y, Herbina N, Bernatoniene J. Natural Herbal Non-Opioid Topical Pain Relievers—Comparison with Traditional Therapy. Pharmaceutics. 2022 Nov 29;14(12):2648.
Yip YB, Tse SHM. An experimental study on the effectiveness of acupressure with aromatic lavender essential oil for sub-acute, non-specific neck pain in Hong Kong. Complement Ther Clin Pract. 2006 Feb;12(1):18–26.
Rafie S, Namjoyan F, Golfakhrabadi F, Yousefbeyk F, Hassanzadeh A. Effect of lavender essential oil as a prophylactic therapy for migraine: A randomized controlled clinical trial. J Herb Med. 2016 Mar 1;6(1):18–23.
Koto R, Imamura M, Watanabe C, Obayashi S, Shiraishi M, Sasaki Y, et al. Linalyl Acetate as a Major Ingredient of Lavender Essential Oil Relaxes the Rabbit Vascular Smooth Muscle through Dephosphorylation of Myosin Light Chain: J Cardiovasc Pharmacol. 2006 Jul;48(1):850–6.
Firoozeei TS, Feizi A, Rezaeizadeh H, Zargaran A, Roohafza HR, Karimi M. The antidepressant effects of lavender (Lavandula angustifolia Mill.): A systematic review and meta-analysis of randomized controlled clinical trials. Complement Ther Med. 2021 Jun; 59:102679.
Ghaderi F, Solhjou N. The effects of lavender aromatherapy on stress and pain perception in children during dental treatment: A randomized clinical trial. Complement Ther Clin Pract. 2020 Aug; 40:101182.
Abbaszadeh R, Tabari F, Taherian K, Torabi S. Lavender Aromatherapy in Pain Management: A Review. 2017;
Askeur Y, Adil S, Kamel D. Use of aromatherapy for Migraine pain relief. Curr Perspect Med Aromat Plants CUPMAP [Internet]. 2024 Dec 31 [cited 2025 Apr 25]; Available from: https://dergipark.org.tr/en/doi/10.38093/cupmap.1588807
Bavarsad NH, Bagheri S, Kourosh-Arami M, Komaki A. Aromatherapy for the brain: Lavender’s healing effect on epilepsy, depression, anxiety, migraine, and Alzheimer’s disease: A review article. Heliyon. 2023 Aug;9(8): e18492.
Ben Salah M, Abderraba M, Tarhouni MR, Abdelmelek H. Effects of ultraviolet radiation on the kinetics of in vitro percutaneous absorption of lavender oil. Int J Pharm. 2009 Dec;382(1–2):33–8.
Sasannejad P, Saeedi M, Shoeibi A, Gorji A, Abbasi M, Foroughipour M. Lavender Essential Oil in the Treatment of Migraine Headache: A Placebo-Controlled Clinical Trial. Eur Neurol. 2012 Apr 17;67(5):288–91.
Lee SH, Chow PS, Yagnik CK. Developing Eco-Friendly Skin Care Formulations with Microemulsions of Essential Oil. Cosmetics. 2022 Mar 4;9(2):30.
Guo J, Hu X, Wang J, Yu B, Li J, Chen J, et al. Safety and efficacy of compound methyl salicylate liniment for topical pain: A multicenter real-world study in China. Front Pharmacol. 2022 Oct 21; 13:1015941.
FDA Essential Oil Gras List.
Yuan R, Zhang D, Yang J, Wu Z, Luo C, Han L, et al. Review of aromatherapy essential oils and their mechanism of action against migraines. J Ethnopharmacol. 2021 Jan; 265:113326.
Stone T, Tran J. Effectiveness of eucalyptus for pain management: An integrative review.
Dewanjee S, Sohel M, Hossain MS, Ansari F, Islam MT, Sultana F, et al. A comprehensive review on clinically proven natural products in the management of nerve pain, with mechanistic insights. Heliyon. 2023 May;9(5): e15346.
Fahimnia F, Nemattalab M, Hesari Z. Development and characterization of a topical gel, containing lavender (Lavandula angustifolia) oil loaded solid lipid nanoparticles. BMC Complement Med Ther. 2024 Apr 8;24(1):155.
Mahanty J, Rasheed SH, Kumar S, Singh H, Sharma A. Potential of Essential Oils as Alternative Permeation Enhancers for Transdermal Delivery. World J Tradit Chin Med. 2023 Jul;9(3):258–69.
Sosnowska K, Tomczykowa M, Winnicka K, Kalemba D, Tomczyk M. In vivo evaluation of the antipsoriatic effect of hydrogel with lavandin essential oil and its main components after topical application. Acta Pol Pharm - Drug Res. 2023 Mar 3;79(6):841–54.
Pergolizzi JV, Taylor R, LeQuang JA, Raffa RB, the NEMA Research Group. The role and mechanism of action of menthol in topical analgesic products. J Clin Pharm Ther. 2018 Jun;43(3):313–9.
Fatmawati F, Nirmala N, Muhsinin S. Review of Menthol on Pain Relief Formulations.
Hoang D, Wong A, Olympia RP. Looking Back to Move Forward: The Current State of Research on the Clinical Applications of Camphor- and Menthol-Containing Agents. Cureus. 2023 Jul;15(7): e41426.
Li Z, Zhang H, Wang Y, Li Y, Li Q, Zhang L. The distinctive role of menthol in pain and analgesia: Mechanisms, practices, and advances. Front Mol Neurosci. 2022; 15:1006908.
Kailash Sahu. Development and characterized analgesic herbal balm using herbs as a medicine. GSC Adv Res Rev. 2024 Jun 30;19(3):122–7.
Hejazi L, Mahboubi-Rabbani M, Mahdavi V, Alemi M, Khanniri E, Bayanati M. A critical review on sodium benzoate from health effects to analytical methods. Results Chem. 2024 Oct; 11:101798.
Benites E, Carrillo E, Heras M, Bourne D. Evaluation of a new topical cream to psoriasis treatment: randomized clinical trial. Adv Tradit Med. 2024 Sep;24(3):755–64.